Clinical Challenges and the Use of Atomoxetine: A Canadian's Experience

ISSN： 1085-0295

Source： Child and Adolescent Psychopharmacology News, Vol.10, Iss.7, 2005-11, pp. : 4-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Atomoxetine

By Sauer John-Michael

Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. : 571-590

Adis International

Access to resources Recommend Favorite

Atomoxetine

By Simpson D. Perry C.M.

Pediatric Drugs, Vol. 5, Iss. 6, 2003-01 ,pp. : 407-415

Adis International

Access to resources Recommend Favorite

Atomoxetine

Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 6, 2004-09 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite

Anagrelide: a decade of clinical experience with its use for the treatment of primary thrombocythaemia

By Petrides Petro E

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1781-1798

Informa Healthcare

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P. Keating Gillian M.

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite